TRIOLA ANNA DIAZ (Chief Commercial Officer) reported 1 transaction at ENTASIS THERAPEUTICS HOLDINGS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/11/2022ACC: 0001104659-22-078803
Officer· Chief Commercial Officer
Since Jul 2021
-225K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
225K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−125K
Price / share
—
Trade value
—
% of position
New position
7/11/2022
125K→0.00
Total
Net shares
−125K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/11/2022 | D · Disposition | −125K | — | — | New position | 125K | 0.00 |
| Total | −125K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
100K shares
Shares
−100K
Strike price
2.49
Held after
0.00
Exercisable
—
7/11/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock100K shares | 7/11/2022 | J · J | −100K | 2.49 | — | 0.00 |